The Combined Impact of Serum Albumin and Genetic Risk on VTE: Implications for Early Prevention
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most...
Risk Factors
An Overview of VTE Prevention and Management in Gynecological Cancer Care
As with cancers in general, gynecological cancers also exhibit a clear and increasingly significant association with...
Thromboprophylaxis in Portuguese Cancer Outpatients: Real-World Insights and Patient Characterization
Venous thromboembolism (VTE) affects up to 20% of cancer patients, presenting a four-to-seven-fold increased risk...
New Predictive Model for Bleeding in Anticoagulated VTE Cancer Patients – (B-CAT Score)
In patients with active cancer who develop venous thromboembolism (Ca-VTE), major bleeding emerges as the most serious...
KRAS-activating mutations: an independent risk factor for VTE?
Colorectal cancer (CRC) is the third most common type of cancer in Europe , after breast and prostate cancer, and...
Risk stratification of PE in the cancer patient
During the ICTHIC webinar titled “Management of CAT: Lung Cancer Focus,” Professor António Araújo...
Unveiling the Link: Neutrophil Extracellular Traps, Occult Cancer, and VTE
Neutrophils, the predominant white blood cells in humans, hold a vital function within the immune response by serving...
Can Elevated D-dimer Levels Predict Concomitant and Future Cancer Diagnoses in Patients with Acute Pulmonary Embolism?
The relationship between cancer and thrombosis is a well-established and intricate interplay within the realm of...
Can Thrombophilia Gene Mutations be Predictors of VTE in Ambulatory Cancer Patients Undergoing Chemotherapy?
Thrombophilia refers to a group of conditions where the blood has an elevated tendency to form clots. It can stem from...
Arterial thromboembolism in patients with cancer and atrial fibrillation
Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...